|
A. BU-ISSON ET AL., ALIMENTARY PHARMACOLOGY & THERAPEUTICS., vol. 43, no. 10, 8 March 2016 (2016-03-08), pages 1069 - 1079
|
|
A. BUISSON ET AL: "Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases", ALIMENTARY PHARMACOLOGY & THERAPEUTICS., vol. 43, no. 10, 8 March 2016 (2016-03-08), GB, pages 1069 - 1079, XP055403209, ISSN: 0269-2813, DOI: 10.1111/apt.13585
*
|
|
ALVAREZ F; BERG PA; BIANCHI FB; BIANCHI L; BURROUGHS AK; CANCADO EL ET AL.: "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis", J HEPATOL., vol. 31, no. 5, 1 November 1999 (1999-11-01), pages 929 - 38, XP055403358
|
|
ANDREW CAMPBELL: "Autoimmunity and the Gut.", AUTOIMMUNE DISEASES, vol. 2014, pages 12
|
|
AUSUBEL ET AL.: "Current Protocols in Molecular Biology", 1999, JOHN WILEY & SONS, INC.
|
|
BAO, J. CHROMATOGR. B. BIOMED. SCI., vol. 699, 1997, pages 463 - 480
|
|
BAUMGART DC; SANDBORN WJ: "Crohn's disease", THE LANCET, vol. 380, no. 9853, 9 November 2012 (2012-11-09), pages 1590 - 605
|
|
BIGG HF; WAIT R; ROWAN AD; CAWSTON TE: "The Mammalian Chitinase-like Lectin, YKL-40, Binds Specifically to Type I Collagen and Modulates the Rate of Type I Collagen Fibril Formation", J BIOL CHEM., vol. 281, no. 30, 28 July 2006 (2006-07-28), pages 21082 - 95
|
|
BOOT RG; ACHTERBERG TAE VAN; AKEN BE VAN; RENKEMA GH; JACOBS MJHM; AERTS JMFG ET AL.: "Strong Induction of Members of the Chitinase Family of Proteins in Atherosclerosis", ARTE-RIOSCLER THROMB VASC BIOL., vol. 19, no. 3, 1 March 1999 (1999-03-01), pages 687 - 94, XP000874580
|
|
COFFMAN F D, CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCE, vol. 45, no. 6, 1 January 2008 (2008-01-01), pages 531 - 562
|
|
COFFMAN F D: "Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics", CRITICAL REVIEWS IN CLINICAL LABORATORY SCIEN, CRC PRESS, BACA RATON, FL, US, vol. 45, no. 6, 1 January 2008 (2008-01-01), pages 531 - 562, XP008110639, ISSN: 1040-8363, DOI: 10.1080/10408360802334743
*
|
|
COJOCARU ET AL., MAEDICA (BUCHAR, vol. 6, no. 1, January 2011 (2011-01-01), pages 45 - 51
|
|
CONRAD ET AL., AUTOIMMUNITY REVIEWS, vol. 13, no. 4-5, 1 April 2014 (2014-04-01), pages 463 - 466
|
|
CONRAD K; ROGGENBUCK D; LAASS MW: "Diagnosis and classification of ulcerative colitis", AUTOIMMUN REV, vol. 13, 2014, pages 463 - 6, XP055403526, DOI: doi:10.1016/j.autrev.2014.01.028
|
|
DANESE S; FIOCCHI C.: "Ulcerative Colitis", N ENGL J MED., vol. 365, 3 November 2011 (2011-11-03), pages 1713 - 25
|
|
DE CEUNINCK F; GAUFILLIER S; BONNAUD A; SABATINI M; LESUR C; PASTOUREAU P: "YKL-40 (Carti-lage gp-39) Induces Proliferative Events in Cultured Chondrocytes and Synoviocytes and In-creases Glycosaminoglycan Synthesis in Chondrocytes", BIOCHEM BIOPHYS RES COMMUN, vol. 285, no. 4, 27 July 2001 (2001-07-27), pages 926 - 31
|
|
ELKE M. HENNES ET AL: "Simplified criteria for the diagnosis of autoimmune hepatitis", HEPATOLOGY, vol. 48, no. 1, 1 July 2008 (2008-07-01), pages 169 - 176, XP055403359, ISSN: 0270-9139, DOI: 10.1002/hep.22322
*
|
|
EVANS ET AL., J. MED. CHEM., vol. 30, 1987, pages 1229
|
|
FAUCHERE, ADV. DRUG RES., vol. 15, 1986, pages 29
|
|
FINK ET AL., J. CLIN. CHEM. CLIN. BIOL. CHEM., vol. 27, 1989, pages 261 - 276
|
|
FUSETTI F; PIJNING T; KALK KH; BOS E; DIJKSTRA BW: "Crystal Structure and Carbohydrate-binding Properties of the Human Cartilage Glycoprotein-39", J BIOL CHEM., vol. 278, no. 39, 26 September 2003 (2003-09-26), pages 37753 - 60
|
|
HAKALA BE; WHITE C; RECKLIES AD: "Human cartilage gp-39, a major secretory product of ar-ticular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family", J BIOL CHEM., vol. 268, no. 34, 5 December 1993 (1993-12-05), pages 25803 - 10
|
|
HANAUER ET AL., AM. J. GASTROENTEROL., vol. 92, 1997, pages 559 - 566
|
|
HASHIDA ET AL., J. CLIN. LAB. ANAL., vol. 11, 1997, pages 267 - 86
|
|
HENNES EM; ZENIYA M; CZAJA AJ; PARES A; DALEKOS GN; KRAWITT EL ET AL.: "Simplified criteria for the diagnosis of autoimmune hepatitis", HEPATOLOGY, vol. 48, no. 1, 1 July 2008 (2008-07-01), pages 169 - 76, XP055403359, DOI: doi:10.1002/hep.22322
|
|
HENNES ET AL., HEPATOLOGY, vol. 48, no. 1, 1 July 2008 (2008-07-01), pages 169 - 176
|
|
HUEBER ET AL., ARTHRITIS & RHEUMA, vol. 52, no. 9, 1 September 2005 (2005-09-01), pages 2645 - 2655
|
|
HUEBER WOLFGANG ET AL: "Antigen microarray profiling of autoantibodies in rheumatoid arthritis", ARTHRITIS & RHEUMA, WILEY INTERSCIENCE, US, vol. 52, no. 9, 1 September 2005 (2005-09-01), pages 2645 - 2655, XP009101906, ISSN: 0004-3591, DOI: 10.1002/ART.21269
*
|
|
JASKOWSKI TD; LITWIN CM; HILL HR: "Analysis of Serum Antibodies in Patients Suspected of Having Inflammatory Bowel Disease", CLIN VACCINE IMMUNOL., vol. 13, no. 6, 1 June 2006 (2006-06-01), pages 655 - 60
|
|
JEPSEN P; GRONBAEK L; VILSTRUP H.: "Worldwide Incidence of Autoimmune Liver Disease", DIG DIS., vol. 33, no. 2, 2015, pages 2 - 12
|
|
JOHANSEN JS; CHRISTOFFERSEN P; MOLLER S; PRICE PA; HENRIKSEN JH; GARBARSCH C ET AL.: "Serum YKL-40 is increased in patients with hepatic fibrosis", J HEPATOL., vol. 32, no. 6, June 2000 (2000-06-01), pages 911 - 20, XP002523835, DOI: doi:10.1016/S0168-8278(00)80095-1
|
|
JOHANSEN JS; JENSEN HS; PRICE PA: "A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid", BR J RHEUMATOL., vol. 32, no. 11, November 1993 (1993-11-01), pages 949 - 55, XP002041907, DOI: doi:10.1093/rheumatology/32.11.949
|
|
JOHANSEN JS; MILMAN N; HANSEN M; GARBARSCH C; PRICE PA; GRAUDAL N.: "Increased serum YKL-40 in patients with pulmonary sarcoidosis—a potential marker of disease activity?", RESPIR MED., vol. 99, no. 4, 1 April 2005 (2005-04-01), pages 396 - 402, XP004780205, DOI: doi:10.1016/j.rmed.2004.09.016
|
|
JOHANSEN JS; STOLTENBERG M; HANSEN M; FLORESCU A; HORSLEV-PETERSEN K; LORENZEN I ET AL.: "Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease ac-tivi-ty", RHEUMATOLOGY, vol. 38, no. 7, 1 July 1999 (1999-07-01), pages 618 - 26, XP002523828, DOI: doi:10.1093/rheumatology/38.7.618
|
|
JOHANSEN JS; WILLIAMSON MK; RICE JS; PRICE PA: "Identification of proteins secreted by human osteoblastic cells in culture", J BONE MINER RES OFF J AM SOC BONE MINER RES, vol. 7, no. 5, May 1992 (1992-05-01), pages 501 - 12
|
|
JOHANSEN JS; WILLIAMSON MK; RICE JS; PRICE PA: "Identification of proteins secreted by human osteoblastic cells in culture", J BONE MINER RES., vol. 7, no. 5, 1 May 1992 (1992-05-01), pages 501 - 12
|
|
JOOSSENS S; VERMEIRE S; VAN STEEN K; GODEFRIDIS G; CLAESSENS G; PIERIK M ET AL.: "Pancreatic autoantibodies in inflammatory bowel disease", INFLAMM BOWEL DIS., vol. 10, no. 6, 1 November 2004 (2004-11-01), pages 771 - 7
|
|
KARSTEN CONRAD ET AL: "Diagnosis and classification of ulcerative colitis", AUTOIMMUNITY REVIEWS, vol. 13, no. 4-5, 1 April 2014 (2014-04-01), NL, pages 463 - 466, XP055403526, ISSN: 1568-9972, DOI: 10.1016/j.autrev.2014.01.028
*
|
|
KELLEHER TB; MEHTA SH; BHASKAR R; SULKOWSKI M; ASTEMBORSKI J; THOMAS DL ET AL.: "Predic-tion of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index", J HEPATOL., vol. 43, no. l, July 2005 (2005-07-01), pages 78 - 84
|
|
KOUTROUBAKIS ET AL., INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol. 18, no. 3, 1 May 2003 (2003-05-01), pages 254 - 259
|
|
KOUTROUBAKIS IE; PETINAKI E; DIMOULIOS P; VARDAS E; ROUSSOMOUSTAKAKI M; MANIATIS AN ET AL.: "Increased serum levels of YKL-40 in patients with inflammatory bowel disease", INT J COL-ORECTAL DIS., vol. 18, no. 3, 1 May 2003 (2003-05-01), pages 254 - 9
|
|
KOUTROUBAKIS IOANNIS E ET AL: "Increased serum levels of YKL-40 in patients with inflammatory bowel disease", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, SPRINGER VERLAG, BERLIN, DE, vol. 18, no. 3, 1 May 2003 (2003-05-01), pages 254 - 259, XP002523829, ISSN: 0179-1958, [retrieved on 20021130], DOI: 10.1007/S00384-002-0446-Z
*
|
|
KRUITHOF E; BAETEN D; DE RYCKE L; VANDOOREN B; FOELL D; ROTH J ET AL.: "Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis", ARTHRITIS RES THER., vol. 7, 2005, pages R569, XP021011589, DOI: doi:10.1186/ar1698
|
|
LAASS ET AL., AUTOIMMUNITY REVIEWS, vol. 13, no. 4-5, 1 April 2014 (2014-04-01), pages 467 - 471
|
|
LAASS MW; ROGGENBUCK D; CONRAD K.: "Diagnosis and classification of Crohn's disease", AUTOIMMUN REV, vol. 13, 2014, pages 467 - 71, XP055403529, DOI: doi:10.1016/j.autrev.2014.01.029
|
|
MALINDA KM; PONCE L; KLEINMAN HK; SHACKELTON LM; MILLIS AJT: "Gp38k, a Protein Synthe-sized by Vascular Smooth Muscle Cells, Stimulates Directional Migration of Human Um-bili-cal Vein Endothelial Cells", EXP CELL RES., vol. 250, no. 1, 10 July 1999 (1999-07-10), pages 168 - 73
|
|
MARTIN W. LAASS ET AL: "Diagnosis and classification of Crohn's disease", AUTOIMMUNITY REVIEWS, vol. 13, no. 4-5, 1 April 2014 (2014-04-01), NL, pages 467 - 471, XP055403529, ISSN: 1568-9972, DOI: 10.1016/j.autrev.2014.01.029
*
|
|
MATSUMOTO T; TSURUMOTO T.: "Serum YKL-40 Levels in Rheumatoid Arthritis: Correlations Between Clinical and Laborarory Parameters [Internet", PUBMED JOURNALS, 5 June 2017 (2017-06-05), Retrieved from the Internet <URL:https://ncbi.nlm.nih.gov/labs/articles/11791636>
|
|
MAZIERES B; GARNERO P; GUEGUEN A; ABBAL M; BERDAH L; LEQUESNE M ET AL.: "Molecular mark-ers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis", THE ECHODIAH* COHORT. ANN RHEUM DIS., vol. 65, no. 3, March 2006 (2006-03-01), pages 354 - 9
|
|
MIZOGUCHI E.: "Chitinase 3-Like-1 Exacerbates Intestinal Inflammation by Enhancing Bacterial Adhesion and Invasion in Colonic Epithelial Cells", GASTROENTEROLOGY, vol. 130, no. 2, February 2006 (2006-02-01), pages 398 - 411, XP005284543, DOI: doi:10.1053/j.gastro.2005.12.007
|
|
MONTAGNA GL; D'ANGELO S; VALENTINI G: "Cross-sectional evaluation of YKL-40 serum con-centrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease", J RHEUMATOL., vol. 30, no. 10, 1 October 2003 (2003-10-01), pages 2147 - 51
|
|
MUNKHOLM P.: "Serum YKL-40, a Potential New Marker of Disease Activity in Patients with Inflammatory Bowel Disease", SCAND J GASTROENTEROL [INTERNET]. SCAND J GASTROENTEROL., vol. 38, no. 6, 1 January 2003 (2003-01-01), pages 599 - 605, XP009195376, DOI: doi:10.1080/00365520310000537
|
|
NISHIKAWA KC; MILLIS AJT: "gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells", EXP CELL RES., vol. 287, no. 1, 1 July 2003 (2003-07-01), pages 79 - 87, XP002584701, DOI: doi:10.1016/S0014-4827(03)00069-7
|
|
NORDENBAEK C; JOHANSEN JS; JUNKER P; BORREGAARD N; SORENSEN O; PRICE PA: "YKL-40, a Ma-trix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Com-munity-Acquired Pneumonia Requiring Hospitalization", J INFECT DIS., vol. 180, no. 5, 1 November 1999 (1999-11-01), pages 1722 - 6
|
|
NYIRKOS P; GOLDS EE: "Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period", BIOCHEM J., vol. 269, no. 1, 1 July 1990 (1990-07-01), pages 265 - 8
|
|
PANAYI GS: "Targeting of cells involved in the pathogenesis of rheumatoid arthritis", RHEUMATOL OXF ENGL., vol. 38, no. 2, November 1999 (1999-11-01), pages 8 - 10
|
|
PNAS USA, vol. 9521, 13 October 1998 (1998-10-13), pages 12179 - 84
|
|
RECKLIES AD; WHITE C; LING H.: "The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways", BIOCHEM J., vol. 365, 1 July 2002 (2002-07-01), pages 119 - 26, XP002382568, DOI: doi:10.1042/BJ20020075
|
|
REHLI M; KRAUSE SW; ANDREESEN R: "Molecular Characterization of the Gene for Human Carti-lage gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage Differentiation", GENOMICS, vol. 43, no. 2, 15 July 1997 (1997-07-15), pages 221 - 5
|
|
RENKEMA GH; BOOT RG; AU FL; DONKER-KOOPMAN WE; STRIJLAND A; MUIJSERS AO ET AL.: "Chi-totriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages", EUR J BIO-CHEM, vol. 251, no. 1-2, 1 January 1998 (1998-01-01), pages 504 - 9
|
|
ROGGENBUCK D; HAUSDORF G; MARTINEZ-GAMBOA L; REINHOLD D; BUTTNER T; JUNGBLUT PR ET AL.: "Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease", GUT., vol. 58, no. 12, 1 December 2009 (2009-12-01), pages 1620 - 8
|
|
ROGGENBUCK D; REINHOLD D; BAUMGART DC; SCHIERACK P; CONRAD K; LAASS MW: "Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype", ADV CLIN CHEM, vol. 77, 2016, pages 77 - 101
|
|
ROGGENBUCK D; REINHOLD D; SCHIERACK P; BOGDANOS DP; CONRAD K; LAASS MW: "Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges", CLIN CHEM LAB MED, vol. 52, 2014, pages 483 - 94, XP055130857, DOI: doi:10.1515/cclm-2013-0801
|
|
ROGGENBUCK D; REINHOLD D; WERNER L; SCHIERACK P; BOGDANOS DP; CONRAD K.: "Glycoprotein 2 in Crohn's disease", ADV CLIN CHEM, vol. 60, 2013, pages 187 - 208
|
|
RONGEN ET AL., J. IMMUNOL. METHODS, vol. 204, 1997, pages 105 - 133
|
|
SCHMALZING ET AL., ELECTROPHORESIS, vol. 18, 1997, pages 2184 - 2193
|
|
SELF ET AL., CURR. OPIN. BIOTECHNOL., vol. 7, 1996, pages 60 - 65
|
|
SHACKEL NA; MCGUINNESS PH; ABBOTT CA; GORRELL MD; MCCAUGHAN GW: "Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization", HEPATOL BALTIM MD., vol. 38, no. 3, September 2003 (2003-09-01), pages 577 - 88, XP002357884, DOI: doi:10.1053/jhep.2003.50376
|
|
SHACKELTON LM; MANN DM; MILLIS AJT: "Identification of a 38-kDa Heparin-binding Glycoprotein (gp38k) in Differentiating Vascular Smooth Muscle Cells as a Member of a Group of Proteins Associated with Tissue Remodeling", J BIOL CHEM., vol. 270, no. 22, 2 June 1995 (1995-06-02), pages 13076 - 83, XP002039027, DOI: doi:10.1074/jbc.270.22.13076
|
|
TRAN A; BENZAKEN S; SAINT-PAUL MC; GUZMAN-GRANIER E; HASTIER P; PRADIER C ET AL.: "Chon-drex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease", EUR J GASTROENTEROL HEPATOL., vol. 12, no. 9, September 2000 (2000-09-01), pages 989 - 93
|
|
TRUELOVE ET AL., BR. MED. J., vol. 12, 1955, pages 1041 - 1048
|
|
VEBER; FREIDINGER, TINS, 1985, pages 392
|
|
VERHEIJDEN ET AL., ARTHRITIS & RHEUMATISM, vol. 40, no. 6, 1 June 1997 (1997-06-01), pages 1115 - 1125
|
|
VERHEIJDEN G F M ET AL: "HUMAN CARTILAGE GLYCOPROTEIN-39 AS A CANDIDATE AUTOANTIGEN IN RHEUMATOID ARTHRITIS", ARTHRITIS & RHEUMATISM, WILEY INTERSCIENCE, US, vol. 40, no. 6, 1 June 1997 (1997-06-01), pages 1115 - 1125, XP002039029, ISSN: 0004-3591
*
|
|
VOLCK B; JOHANSEN JS; STOLTENBERG M; GARBARSCH§ C; PRICE PA; 0STERGAARD M ET AL.: "Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology", OSTEOARTHRITIS CARTILAGE, vol. 9, no. 3, 1 April 2001 (2001-04-01), pages 203 - 14
|
|
VOLCK B; OSTERGAARD K; JOHANSEN JS; GARBARSCH C; PRICE PA: "The distribution of YKL-40 in osteoarthritic and normal human articular cartilage", SCAND J RHEUMATOL., vol. 28, no. 3, 1999, pages 171 - 9
|
|
WASHINGTON M: "Autoimmune liver disease: overlap and outliers", MODERN PATHOLOGY, vol. 20, 2007, pages S15 - S30
|
|
YUSUF ERZIN ET AL., JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 23, 1 August 2008 (2008-08-01), pages e357 - e362
|
|
YUSUF ERZIN ET AL: "Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 23, no. 8pt2, 1 August 2008 (2008-08-01), AU, pages e357 - e362, XP055403215, ISSN: 0815-9319, DOI: 10.1111/j.1440-1746.2007.05121.x
*
|
|
ZHENG M; WEI-MIN C; JUN-KANG Z; SHAO-MING Z; RONG-HUA L: "Determination of serum lev-els of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value", ACTA TROP., vol. 96, no. 2-3, November 2005 (2005-11-01), pages 148 - 52
|